arrow
S

Shingo Matsumoto

university of glasgow
H指数:60
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Genomic profiles of pathogenic and moderate-penetrance germline variants associated with risk of early-onset lung adenocarcinoma

与早发性肺腺癌风险相关的致病性和中等外显率生殖细胞系变异的基因组特征

2025-06-150
OAAI
Finerenone and Atrial Fibrillation in Heart Failure A Secondary Analysis of the FINEARTS-HF Randomized Clinical Trial

Finerenone和心房颤动在心力衰竭中的关系:FINEARTS-HF随机临床试验的二次分析

2025-03-290
PRE
Finerenone, Serum Potassium, and Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction
2025-01-011
OA
Initial Decline in Glomerular Filtration Rate With Finerenone in HFmrEF/HFpEFA Prespecified Analysis of FINEARTS-HF

使用非奈利酮治疗HFmrEF/HFpEF患者时肾小球滤过率的初始下降:FINEARTS-HF研究的预设分析

2025-01-013
OAAI
Enhancing the durability of aluminium-foil anodes in rechargeable lithium batteries via uniformly distributed alloy addition in the matrix phase ( jan , 10.1039/D4TA07956F , 2025)

通过在基体相中均匀分布的合金添加来增强可充电锂离子电池铝箔阳极的耐久性 (Jan, 10.1039/D4TA07956F, 2025)

2025-01-010
OA
Effects of sacubitril/valsartan according to background beta-blocker therapy in patients with heart failure and reduced ejection fraction: Insights from PARADIGM-HF
2024-11-190
PRE
Beta-blocker use and outcomes in patients with heart failure and mildly reduced and preserved ejection fraction

射血分数轻度降低和保留的心力衰竭患者 β 受体阻滞剂的使用和预后

2024-08-310
PRE
Identification of Genomic Predictors of Muscle Fiber Size
CELLS
IF5.2
2024-07-183
OAAI